Delivery Order SPE2DB20D7061-SPE2DB25FSPG6
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,887.66 to AmerisourceBergen Drug Corp for the supply of Pimecrolimus 1% Cream in 30-gram units. This firm fixed price, non-competitive delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025. The pharmaceutical product will be delivered to the prime contractor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- This is a $1,139.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 100 gram tubes of Pimecrolimus 1% cream. The contract has an ultimate completion date of July 3, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Pimecrolimus 1% Cream, a prescription medication, with a total ceiling value of $6,177.35 and a period of performance through January 24, 2025. The contract is an open competition, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
- This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,963.14 firm fixed price contract is for the supply of Pimecrolimus 1% Cream in 100g containers. There is no set-aside designation for this order, which has an ultimate completion date of August 21, 2024. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of...
- This is a $3,328.04 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a 30g tube of 1% pimecrolimus cream. The contract has an ultimate completion date of July 7, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Pimecrolimus 1% Cream in 60-gram tubes, with a ceiling value of $1,759.49 and a completion date of March 14, 2025. The contract is a firm-fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,277.38 contract is for the delivery of Pimecrolimus 1% Cream, 100 grams. The contract has a performance period through March 4, 2024 and was awarded on March 1, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Pimecrolimus 1% Cream 30 GM. The contract has a firm-fixed price of $1,474.22 and a completion date of June 16, 2025. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM) and has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $2,637.47 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Pimecrolimus 1% cream. As the prime contractor, Amerisourcebergen will supply 100 grams of the prescribed topical cream to fulfill requirements under the contract. Performance will occur at Amerisourcebergen's Conshohocken, Pennsylvania facility by August 4, 2023. The Defense Logistics Agency leverages contracts such as this to efficiently procure medical supplies in...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PIMECROLIMUS 1% CREAM 100GM, with a ceiling value of $1,242.93 and a completion date of November 30, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB25FSPG6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Pimecrolimus 1% Cream in 30-gram quantities, with a ceiling value of $4,473.45. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is set for ultimate completion by August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Pimecrolimus is an immunosuppressive topical medication commonly used in military and veteran healthcare settings for treating inflammatory skin conditions. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a substantial value of $999,999,999.00 through December 2026. The broader IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen has demonstrated capability to fulfill federal requirements through open competition, serving various government healthcare systems including the Defense Health Agency and U.S. Coast Guard across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 8/13/25 |